Skip to main content
MediPharm Labs Corp. logo

MediPharm Labs Corp. — Investor Relations & Filings

Ticker · LABS LEI · 875500SIGS9KXW34K754 TSX Manufacturing
Open in API
Filings indexed 274 across all filing types
Latest filing 2026-03-30 Audit Report / Informat…
Country CA Canada
Listing TSX LABS

About MediPharm Labs Corp.

https://medipharmlabs.com/

MediPharm Labs Corp. is a full-service pharmaceutical company specializing in the development, formulation, processing, packaging, and distribution of precision-based, advanced cannabinoid products. Operating from Good Manufacturing Practices (GMP) certified facilities, the company focuses on producing pharma-quality cannabis Active Pharmaceutical Ingredients (API), concentrates, and derivative products. Utilizing strict manufacturing standards and ISO standard cleanrooms, MediPharm Labs ensures its offerings are pure, trusted, and precisely dosable for patients and consumers. Services include wholesale and white label platforms for domestic and international clients. The company holds a Pharmaceutical Drug Establishment License, enabling the manufacture of pharmaceutical drugs containing cannabis.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document begins with an “Independent Auditor’s Report” and contains detailed audit opinion sections (Opinion, Basis for Opinion, Key Audit Matters, Auditor’s Responsibilities) followed by the full consolidated financial statements and extensive notes. There is no narrative letter to shareholders or management discussion beyond a reference to MD&A, indicating this is the standalone audited financial statements rather than a full annual report or earnings release. This matches the “Audit Report / Information” category. FY 2025
2026-03-30 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by MediPharm Labs announcing a new supply agreement for medicinal cannabis in Costa Rica. It follows the standard format of a corporate news release, including a headline, dateline, quotes from executives, company background, and a cautionary note regarding forward-looking statements. Since it does not fit into specific categories like financial reports, board changes, or dividend notices, and is a general corporate announcement, it falls under the 'Regulatory Filings' (RNS) category as the fallback for general corporate news.
2026-01-13 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by MediPharm Labs Corp. regarding the impact of U.S. cannabis rescheduling on their business operations and clinical trial supply capabilities. It does not constitute a formal financial report, audit, or regulatory filing, but rather a corporate announcement intended for investors and the public. As it does not fit into specific categories like earnings releases or M&A, it falls under the general regulatory/corporate announcement category.
2025-12-19 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by MediPharm Labs announcing a business milestone (the first shipment of products to France). It does not constitute a formal financial report (10-K, IR), a transcript, or a specific regulatory filing like a proxy or dividend notice. As it is a general corporate announcement regarding operational progress and market expansion, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2025-12-04 English
News release - English.pdf
Legal Proceedings Report Classification · 1% confidence The document is a press release issued by MediPharm Labs regarding the dismissal of a defamation lawsuit (legal proceedings) and an alert regarding unauthorized press releases. It does not fit into financial reporting categories like 10-K or IR, nor is it a report publication announcement. It is a corporate announcement concerning legal matters and regulatory issues, which falls under the 'Legal Proceedings Report' category.
2025-11-14 English
Other.pdf
Regulatory Filings Classification · 1% confidence The document is an official Health Canada cannabis cultivation and processing licence issued to ABcann Medicinals Inc. It details authorized activities, conditions, and validity periods under the Cannabis Act. This type of regulatory authorization does not fit into standard financial reporting categories like 10-K, ER, or IR. As it is a regulatory document issued by a government body to a company, it falls under the 'Regulatory Filings' category as the most appropriate fallback.
2025-11-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.